Literature DB >> 18523150

Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis.

Alicia R Folgueras1, Fernando Martín de Lara, Alberto M Pendás, Cecilia Garabaya, Francisco Rodríguez, Aurora Astudillo, Teresa Bernal, Rubén Cabanillas, Carlos López-Otín, Gloria Velasco.   

Abstract

Proteolytic events at the cell surface are essential in the regulation of signal transduction pathways. During the past years, the family of type II transmembrane serine proteases (TTSPs) has acquired an increasing relevance because of their privileged localization at the cell surface, although our current understanding of the biologic function of most TTSPs is limited. Here we show that matriptase-2 (Tmprss6), a recently described member of the TTSP family, is an essential regulator of iron homeostasis. Thus, Tmprss6(-/-) mice display an overt phenotype of alopecia and a severe iron deficiency anemia. These hematologic alterations found in Tmprss6(-/-) mice are accompanied by a marked up-regulation of hepcidin, a negative regulator of iron export into plasma. Likewise, Tmprss6(-/-) mice have reduced ferroportin expression in the basolateral membrane of enterocytes and accumulate iron in these cells. Iron-dextran therapy rescues both alopecia and hematologic alterations of Tmprss6(-/-) mice, providing causal evidence that the anemic phenotype of these mutant mice results from the blockade of intestinal iron export into plasma after dietary absorption. On the basis of these findings, we conclude that matriptase-2 activity represents a novel and relevant step in hepcidin regulation and iron homeostasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523150     DOI: 10.1182/blood-2008-04-149773

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  112 in total

1.  Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels.

Authors:  Irene Pichler; Cosetta Minelli; Serena Sanna; Toshiko Tanaka; Christine Schwienbacher; Silvia Naitza; Eleonora Porcu; Cristian Pattaro; Fabio Busonero; Alessandra Zanon; Andrea Maschio; Scott A Melville; Maria Grazia Piras; Dan L Longo; Jack Guralnik; Dena Hernandez; Stefania Bandinelli; Elmar Aigner; Anthony T Murphy; Victor Wroblewski; Fabio Marroni; Igor Theurl; Carsten Gnewuch; Eric Schadt; Manfred Mitterer; David Schlessinger; Luigi Ferrucci; Derrick R Witcher; Andrew A Hicks; Günter Weiss; Manuela Uda; Peter P Pramstaller
Journal:  Hum Mol Genet       Date:  2010-12-28       Impact factor: 6.150

Review 2.  Murine mutants in the study of systemic iron metabolism and its disorders: an update on recent advances.

Authors:  Thomas B Bartnikas; Mark D Fleming; Paul J Schmidt
Journal:  Biochim Biophys Acta       Date:  2012-01-28

Review 3.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

Review 4.  Type II transmembrane serine proteases.

Authors:  Thomas H Bugge; Toni M Antalis; Qingyu Wu
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

Review 5.  Modulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approaches.

Authors:  Paul J Schmidt; Mark D Fleming
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

Review 6.  Molecular mechanisms of normal iron homeostasis.

Authors:  An-Sheng Zhang; Caroline A Enns
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

7.  An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.

Authors:  Paul J Schmidt; Iva Toudjarska; Anoop K Sendamarai; Tim Racie; Stuart Milstein; Brian R Bettencourt; Julia Hettinger; David Bumcrot; Mark D Fleming
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

8.  Hepcidin targets ferroportin for degradation in hepatocytes.

Authors:  Guillemette Ramey; Jean-Christophe Deschemin; Béatrice Durel; François Canonne-Hergaux; Gaël Nicolas; Sophie Vaulont
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

Review 9.  Iron-refractory iron deficiency anemia: new molecular mechanisms.

Authors:  Yujie Cui; Qingyu Wu; Yiqing Zhou
Journal:  Kidney Int       Date:  2009-09-23       Impact factor: 10.612

Review 10.  Role of matriptase-2 (TMPRSS6) in iron metabolism.

Authors:  Pauline Lee
Journal:  Acta Haematol       Date:  2009-11-10       Impact factor: 2.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.